GBA1 and Parkinson disease: Interestingly, elevated 11C-PK11195 was found in asymptomatic LRRK2 mutation carriers, restricted to those with impaired putaminal dopamine synthesis assessed with 18F-FDOPA [150] and in GBA1 mutation carriers without PD [151].